Table 1. Meningococcal Disease Vaccine Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Meningococcal Disease Vaccine Market Restraints

Table 3. Meningococcal Disease Vaccine Market Trends

Table 4. Meningococcal Disease Vaccine Industry Policy

Table 5. Global Meningococcal Disease Vaccine Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Meningococcal Disease Vaccine Revenue Share by Company, 2019-2024, Ranked by Data of 2024

Table 7. Global Meningococcal Disease Vaccine Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Meningococcal Disease Vaccine Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 9. Global Meningococcal Disease Vaccine Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Meningococcal Disease Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Meningococcal Disease Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Meningococcal Disease Vaccine Manufacturers Product Type

Table 13. Head Office and Meningococcal Disease Vaccine Production Site of Key Manufacturer

Table 14. Meningococcal Disease Vaccine Capacity of Major Manufacturers and Future Plan

Table 15. China Meningococcal Disease Vaccine Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2024

Table 16. China Meningococcal Disease Vaccine Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2024

Table 17. China Meningococcal Disease Vaccine Sales Quantity by Company, 2019-2024, Ranked by Data of 2024

Table 18. Global Meningococcal Disease Vaccine Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Meningococcal Disease Vaccine Production by Region, 2019-2024, (K Units)

Table 20. Global Meningococcal Disease Vaccine Production Forecast by Region, 2024-2030, (K Units)

Table 21. Global Key Players of Meningococcal Disease Vaccine Upstream (Raw Materials)

Table 22. Global Meningococcal Disease Vaccine Typical Customers

Table 23. Meningococcal Disease Vaccine Typical Distributors

Table 24. By Type, Global Meningococcal Disease Vaccine Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Meningococcal Disease Vaccine Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Meningococcal Disease Vaccine Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Meningococcal Disease Vaccine Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Meningococcal Disease Vaccine Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Meningococcal Disease Vaccine Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2019-2030

Table 34. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 35. AstraZeneca Meningococcal Disease Vaccine Models, Specifications, and Application

Table 36. AstraZeneca Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. AstraZeneca Company Profile and Main Business

Table 38. AstraZeneca Recent Developments

Table 39. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position

Table 40. Johnson & Johnson Meningococcal Disease Vaccine Models, Specifications, and Application

Table 41. Johnson & Johnson Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Johnson & Johnson Company Profile and Main Business

Table 43. Johnson & Johnson Recent Developments

Table 44. Mylan N.V Company Information, Head Office, Market Area, and Industry Position

Table 45. Mylan N.V Meningococcal Disease Vaccine Models, Specifications, and Application

Table 46. Mylan N.V Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Mylan N.V Company Profile and Main Business

Table 48. Mylan N.V Recent Developments

Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position

Table 50. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Models, Specifications, and Application

Table 51. Teva Pharmaceutical Industries Ltd Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 53. Teva Pharmaceutical Industries Ltd Recent Developments

Table 54. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position

Table 55. Pfizer Inc Meningococcal Disease Vaccine Models, Specifications, and Application

Table 56. Pfizer Inc Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Pfizer Inc Company Profile and Main Business

Table 58. Pfizer Inc Recent Developments

Table 59. GlaxoSmithKline plc Company Information, Head Office, Market Area, and Industry Position

Table 60. GlaxoSmithKline plc Meningococcal Disease Vaccine Models, Specifications, and Application

Table 61. GlaxoSmithKline plc Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. GlaxoSmithKline plc Company Profile and Main Business

Table 63. GlaxoSmithKline plc Recent Developments

Table 64. Novartis AG Company Information, Head Office, Market Area, and Industry Position

Table 65. Novartis AG Meningococcal Disease Vaccine Models, Specifications, and Application

Table 66. Novartis AG Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Novartis AG Company Profile and Main Business

Table 68. Novartis AG Recent Developments

Table 69. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 70. Sanofi Meningococcal Disease Vaccine Models, Specifications, and Application

Table 71. Sanofi Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Sanofi Company Profile and Main Business

Table 73. Sanofi Recent Developments

Table 74. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position

Table 75. Merck & Co., Inc. Meningococcal Disease Vaccine Models, Specifications, and Application

Table 76. Merck & Co., Inc. Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Merck & Co., Inc. Company Profile and Main Business

Table 78. Merck & Co., Inc. Recent Developments

Table 79. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position

Table 80. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Models, Specifications, and Application

Table 81. F. Hoffmann-La Roche Ltd Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 83. F. Hoffmann-La Roche Ltd Recent Developments

Table 84. Baxter Company Information, Head Office, Market Area, and Industry Position

Table 85. Baxter Meningococcal Disease Vaccine Models, Specifications, and Application

Table 86. Baxter Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Baxter Company Profile and Main Business

Table 88. Baxter Recent Developments

Table 89. BIO-MED Company Information, Head Office, Market Area, and Industry Position

Table 90. BIO-MED Meningococcal Disease Vaccine Models, Specifications, and Application

Table 91. BIO-MED Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. BIO-MED Company Profile and Main Business

Table 93. BIO-MED Recent Developments

Table 94. Bio-Manguinhos Company Information, Head Office, Market Area, and Industry Position

Table 95. Bio-Manguinhos Meningococcal Disease Vaccine Models, Specifications, and Application

Table 96. Bio-Manguinhos Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Bio-Manguinhos Company Profile and Main Business

Table 98. Bio-Manguinhos Recent Developments

Table 99. Walvax Biotechnology Co., Ltd Company Information, Head Office, Market Area, and Industry Position

Table 100. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Models, Specifications, and Application

Table 101. Walvax Biotechnology Co., Ltd Meningococcal Disease Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Walvax Biotechnology Co., Ltd Company Profile and Main Business

Table 103. Walvax Biotechnology Co., Ltd Recent Developments

List of Figures

Figure 1. Meningococcal Disease Vaccine Picture

Figure 2. Global Meningococcal Disease Vaccine Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Meningococcal Disease Vaccine Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Meningococcal Disease Vaccine Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Meningococcal Disease Vaccine Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Meningococcal Disease Vaccine Sales Quantity (K Units) & (2019-2030)

Figure 7. China Meningococcal Disease Vaccine Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Meningococcal Disease Vaccine Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Meningococcal Disease Vaccine Market Share of Global, 2019-2030

Figure 10. Global Meningococcal Disease Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Meningococcal Disease Vaccine Key Participants, Market Share, 2024

Figure 12. Global Meningococcal Disease Vaccine Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Meningococcal Disease Vaccine Capacity Market Share by Region, 2024 VS 2030

Figure 14. Global Meningococcal Disease Vaccine Production Market Share & Forecast by Region, 2019-2030

Figure 15. Meningococcal Disease Vaccine Industry Chain

Figure 16. Meningococcal Disease Vaccine Procurement Model

Figure 17. Meningococcal Disease Vaccine Sales Model

Figure 18. Meningococcal Disease Vaccine Sales Channels, Direct Sales, and Distribution

Figure 19. Polysaccharide

Figure 20. Conjugate

Figure 21. Combination

Figure 22. By Type, Global Meningococcal Disease Vaccine Consumption Value, 2019-2030, US$ Million

Figure 23. By Type, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2019-2030

Figure 24. By Type, Global Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 25. By Type, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2019-2030

Figure 26. By Type, Global Meningococcal Disease Vaccine Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 27. Infant

Figure 28. Child

Figure 29. Aldult

Figure 30. By Application, Global Meningococcal Disease Vaccine Consumption Value, 2019-2030, US$ Million

Figure 31. By Application, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2019-2030

Figure 32. By Application, Global Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 33. By Application, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2019-2030

Figure 34. By Application, Global Meningococcal Disease Vaccine Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 35. By Region, Global Meningococcal Disease Vaccine Consumption Value Market Share, 2019-2030

Figure 36. By Region, Global Meningococcal Disease Vaccine Sales Quantity Market Share, 2019-2030

Figure 37. North America Meningococcal Disease Vaccine Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 38. By Country, North America Meningococcal Disease Vaccine Consumption Value Market Share, 2024

Figure 39. Europe Meningococcal Disease Vaccine Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, Europe Meningococcal Disease Vaccine Consumption Value Market Share, 2024

Figure 41. Asia Pacific Meningococcal Disease Vaccine Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country/Region, Asia Pacific Meningococcal Disease Vaccine Consumption Value Market Share, 2024

Figure 43. South America Meningococcal Disease Vaccine Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, South America Meningococcal Disease Vaccine Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Meningococcal Disease Vaccine Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. U.S. Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 47. By Type, U.S. Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 48. By Application, U.S. Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 49. Europe Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 50. By Type, Europe Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 51. By Application, Europe Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 52. China Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 53. By Type, China Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 54. By Application, China Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 55. Japan Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 56. By Type, Japan Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 57. By Application, Japan Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 58. South Korea Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 59. By Type, South Korea Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 60. By Application, South Korea Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 61. Southeast Asia Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 62. By Type, Southeast Asia Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 63. By Application, Southeast Asia Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 64. India Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 65. By Type, India Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 66. By Application, India Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 67. Middle East & Africa Meningococcal Disease Vaccine Sales Quantity, 2019-2030, (K Units)

Figure 68. By Type, Middle East & Africa Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 69. By Application, Middle East & Africa Meningococcal Disease Vaccine Sales Quantity Market Share, 2024 VS 2030

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up and Top-down Approaches

Figure 73. Top-down Approaches